Literature DB >> 19686849

Defining the role of laminin-332 in carcinoma.

Cherise M Guess1, Vito Quaranta.   

Abstract

The deadly feature of cancer, metastasis, requires invasion of cells through basement membranes (BM), which normally act as barriers between tissue compartments. In the case of many epithelially-derived cancers (carcinomas), laminin-332 (Ln-332) is a key component of the BM barrier. This review provides a historical examination of Ln-332 from its discovery through identification of its functions in BM and possible role in carcinomas. Current understanding points to distinct roles for the three Ln-332 subunits (alpha3, beta3, gamma2) in cell adhesion, extracellular matrix stability, and cell signaling processes in cancer. Given the large number of studies linking Ln-332 gamma2 subunit with cancer prognosis, particular attention is given to the crucial role of this subunit in cancer invasion and to the unanswered questions in this area.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19686849      PMCID: PMC2875997          DOI: 10.1016/j.matbio.2009.07.008

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  191 in total

1.  Kalinin, epiligrin and GB3 antigen: kalinepiligrinin-3?

Authors:  F M Watt; N A Hotchin
Journal:  Curr Biol       Date:  1992-02       Impact factor: 10.834

2.  Wide distribution of laminin-5 gamma 2 chain in basement membranes of various human tissues.

Authors:  H Mizushima; N Koshikawa; K Moriyama; H Takamura; Y Nagashima; F Hirahara; K Miyazaki
Journal:  Horm Res       Date:  1998

3.  Mammalian tolloid metalloproteinase, and not matrix metalloprotease 2 or membrane type 1 metalloprotease, processes laminin-5 in keratinocytes and skin.

Authors:  Dallas P Veitch; Pasi Nokelainen; Kelly A McGowan; Thuong-Thuong Nguyen; Ngon E Nguyen; Robert Stephenson; William N Pappano; Douglas R Keene; Suzanne M Spong; Daniel S Greenspan; Paul R Findell; M Peter Marinkovich
Journal:  J Biol Chem       Date:  2002-12-07       Impact factor: 5.157

4.  Detection of sequence variants in the gene encoding the beta 3 chain of laminin 5 (LAMB3).

Authors:  L Pulkkinen; J A McGrath; A M Christiano; J Uitto
Journal:  Hum Mutat       Date:  1995       Impact factor: 4.878

5.  Basement membrane proteins kalinin and nicein are structurally and immunologically identical.

Authors:  M P Marinkovich; P Verrando; D R Keene; G Meneguzzi; G P Lunstrum; J P Ortonne; R E Burgeson
Journal:  Lab Invest       Date:  1993-09       Impact factor: 5.662

6.  A new nomenclature for the laminins.

Authors:  R E Burgeson; M Chiquet; R Deutzmann; P Ekblom; J Engel; H Kleinman; G R Martin; G Meneguzzi; M Paulsson; J Sanes
Journal:  Matrix Biol       Date:  1994-04       Impact factor: 11.583

7.  Differential expression of laminin 5 (alpha 3 beta 3 gamma 2) by human malignant and normal prostate.

Authors:  J Hao; Y Yang; K M McDaniel; B L Dalkin; A E Cress; R B Nagle
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

Review 8.  Tumour microenvironment: laminin 332 in squamous-cell carcinoma.

Authors:  M Peter Marinkovich
Journal:  Nat Rev Cancer       Date:  2007-05       Impact factor: 60.716

9.  Epiligrin, the major human keratinocyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepidermal blistering skin disease.

Authors:  N Domloge-Hultsch; W R Gammon; R A Briggaman; S G Gil; W G Carter; K B Yancey
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

10.  Development of a new tracking tool for the human monomeric laminin-gamma 2 chain in vitro and in vivo.

Authors:  Naohiko Koshikawa; Tomoko Minegishi; Kazuki Nabeshima; Motoharu Seiki
Journal:  Cancer Res       Date:  2008-01-15       Impact factor: 12.701

View more
  37 in total

1.  Functional role of laminin α1 chain during cerebellum development.

Authors:  Céline Heng; Olivier Lefebvre; Annick Klein; Malia M Edwards; Patricia Simon-Assmann; Gertraud Orend; Dominique Bagnard
Journal:  Cell Adh Migr       Date:  2011 Nov-Dec       Impact factor: 3.405

2.  Matrix-dependent regulation of AKT in Hepsin-overexpressing PC3 prostate cancer cells.

Authors:  Stephanie M Wittig-Blaich; Lukasz A Kacprzyk; Thorsten Eismann; Melanie Bewerunge-Hudler; Petra Kruse; Eva Winkler; Wolfgang S L Strauss; Raimund Hibst; Rudolf Steiner; Mark Schrader; Daniel Mertens; Holger Sültmann; Rainer Wittig
Journal:  Neoplasia       Date:  2011-07       Impact factor: 5.715

3.  Laminin-332 cleavage by matriptase alters motility parameters of prostate cancer cells.

Authors:  Manisha Tripathi; Alka A Potdar; Hironobu Yamashita; Brandy Weidow; Peter T Cummings; Daniel Kirchhofer; Vito Quaranta
Journal:  Prostate       Date:  2011-02-01       Impact factor: 4.104

4.  Laminin 332 expression in breast carcinoma.

Authors:  Soon-Young Kwon; Seoung W Chae; Sharon P Wilczynski; Ahmad Arain
Journal:  Appl Immunohistochem Mol Morphol       Date:  2012-03

Review 5.  Meeting the biologic challenge of colorectal metastases.

Authors:  Harold J Wanebo; Mark LeGolvan; Philip B Paty; Sukamal Saha; Markus Zuber; Michael I D'Angelica; Nancey E Kemeny
Journal:  Clin Exp Metastasis       Date:  2012-10-10       Impact factor: 5.150

Review 6.  Targeting tumor cell motility to prevent metastasis.

Authors:  Trenis D Palmer; William J Ashby; John D Lewis; Andries Zijlstra
Journal:  Adv Drug Deliv Rev       Date:  2011-06-02       Impact factor: 15.470

7.  Targeting the Warburg effect that arises in tumor cells expressing membrane type-1 matrix metalloproteinase.

Authors:  Takeharu Sakamoto; Daigo Niiya; Motoharu Seiki
Journal:  J Biol Chem       Date:  2011-03-03       Impact factor: 5.157

8.  miR-205 regulates basement membrane deposition in human prostate: implications for cancer development.

Authors:  P Gandellini; V Profumo; A Casamichele; N Fenderico; S Borrelli; G Petrovich; G Santilli; M Callari; M Colecchia; S Pozzi; M De Cesare; M Folini; R Valdagni; R Mantovani; N Zaffaroni
Journal:  Cell Death Differ       Date:  2012-05-04       Impact factor: 15.828

9.  Laminin 332 expression and prognosis in breast cancer.

Authors:  Philip M Carpenter; Argyrios Ziogas; Emma M Markham; Alegria S Cantillep; Rui Yan; Hoda Anton-Culver
Journal:  Hum Pathol       Date:  2018-08-17       Impact factor: 3.466

10.  Computational investigation of intrinsic and extrinsic mechanisms underlying the formation of carcinoma.

Authors:  Katarzyna A Rejniak; Vito Quaranta; Alexander R A Anderson
Journal:  Math Med Biol       Date:  2010-11-24       Impact factor: 1.854

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.